+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevention of recurrent vascular access thrombosis in hemodialysis patients a pilot study using aspirin plus sulfinpyrazone



Prevention of recurrent vascular access thrombosis in hemodialysis patients a pilot study using aspirin plus sulfinpyrazone



Haemostasis 16(Suppl. 5): 66




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028961497

Download citation: RISBibTeXText


Related references

Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thrombosis Research 62(6): 737-744, 1991

A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis. Hemodialysis International. International Symposium on Home Hemodialysis 13(1): 19-26, 2009

Recurrent vascular access thrombosis in hemodialysis patients lack of demonstrable blood hypercoagulability. Haemostasis 16(Suppl. 5): 55, 1986

Frequency of anti-heparin-platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis. American Journal of Hematology 69(1): 72-73, 2002

Recurrent vascular access thrombosis in hemodialysis patients is associated with homozygosity for the 677CfwdarwT mutation in the methylene tetrahydrofolate reductase gene. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 157A, Sept, 1997

Combination aspirin plus clopidogrel in the prevention of hemodialysis access graft thrombosis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 291A, 2001

Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study. Vascular Health and Risk Management 9: 361-364, 2013

Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: a retrospective study. International Journal of Clinical Practice 60(12): 1596-1599, 2006

Antiplatelet therapy for prevention of hemodialysis vascular access thrombosis and improving survival. Journal of Nephrology 2019, 2019

Variable flow Doppler vascular access blood flow predicts vascular access thrombosis in hemodialysis patients with PTEE grafts. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 296A-297A, 2001

Prevention of thrombosis by low-dose aspirin in patients on hemodialysis. New England Journal of Medicine 302(3): 179, 1980

Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. New England Journal of Medicine 301(11): 577-579, 1979

A case report of recurrent vascular access thrombosis in a hemodialysis patient reveals combined acquired and inherited thrombophilia. Therapeutic Apheresis and Dialysis 12(2): 190-192, 2008

Focal segmental glomerulosclerosis predisposes to recurrent thrombosis of hemodialysis vascular access Role of weight and urine protein excretion. Journal of the American Society of Nephrology 7(9): 1416, 1996

Vascular access thrombosis in new hemodialysis patients. American Journal of Kidney Diseases 26(2): 341-346, 1995